A Monte Carlo study on the effect of seed design on the interseed attenuation in permanent prostate implants

• Published in: Medical physics (Lancaster) 2008-08, Vol.35 (8), p.3671-3681
• Main Authors: Afsharpour, Hossein, D’Amours, Michel, Coté, Benoit, Carrier, Jean-François, Verhaegen, Frank, Beaulieu, Luc
• Format: Article
• Language: English
• Subjects: Algorithms; Biomedical engineering; Biomedical modeling; brachytherapy; Brachytherapy - instrumentation; Brachytherapy - methods; Dosimetry; encapsulation; Gold; Humans; Isotopes; Male; Models, Biological; Monte Carlo Method; Monte Carlo methods; Monte Carlo simulations; phantoms; Photons; Polymers; Prostatic Neoplasms - pathology; Prostatic Neoplasms - radiotherapy; Prostheses and Implants; prosthetics; Radiotherapy Dosage; Silver; Smart prosthetics; Titanium; Water
• ISSN: 0094-2405; 2473-4209
• DOI: 10.1118/1.2955754

Standard algorithms for postimplant analysis of transperineal interstitial permanent prostate brachytherapy (TIPPB) are based on AAPM Task Group 43 formalism (TG-43), which makes use of a world entirely made of water. This entails an assignment of the prostate, surrounding organs at risk, as well as all brachytherapy seeds present in a permanent prostate implant to water. Brachytherapy seeds are generally made from high atomic number materials. Because of the simultaneous presence of many brachytherapy seeds in a TIPPB, there is a shielding effect causing an attenuation of energy of the emitted photons generally called the “interseed attenuation” (ISA). This study investigates the impact of seed designs and compositions on the interseed attenuation. For this purpose, six brachytherapy seeds covering a wide variety of seed design and composition were modeled with the GEANT4 Monte Carlo (MC) toolkit. MC has allowed calculation of the contribution of each major component (encapsulation and internal components) of a given seed model to ISA separately. The impact of ISA on real clinical implant configurations was also explored. Two clinical postimplant geometries with different brachytherapy seeds were studied with MC simulations. The change in the clinical parameter D90 was observed. This study shows that Nucletron SelectSeed (similar to the Oncura model 6711), ProstaSeed, and Best Medical model 2335 are the most attenuating designs with 4.8%, 3.9%, and 4.6% of D90 reduction, respectively. The least attenuating seed is a Pd 103 seed encapsulated in a polymer shell, the IBt OptiSeed with 1.5%. Finally, based on this systematic study, a new seed design is proposed that is predicted to be the most waterlike brachytherapy seed and thus TG-43 compatible.